Bridgestone’s Sales Dip: What’s Next for the Leading Tire Manufacturer?by Mark Eisenberg 18.02.2024Bridgestone Corporation reports a decrease in truck and bus tire sales, but sees growth in premium tire segment. Plans to ...
Retail Earnings Surge: Is a 2024 Slowdown Looming?by Terry Bingman 18.02.2024Retailers gear up to report Q4 earnings amidst challenges. Positive results expected but stock prices already reflect holiday gains. Potential ...
EV Stocks Brace for Riveting Earnings Amid Market Shakesby Mark Eisenberg 17.02.2024Rivian's earnings report and launch of its low-cost EV platform take center stage this week. Mixed performance in the EV ...
Iridium Adjusts Amid Starlink Rivalry: Hold or Buy?by Mark Eisenberg 16.02.2024Iridium Communications' rating has shifted from Buy to Hold, due to accounting changes and increased competition. Potential value through inventory ...
Canada’s Wholesale Trade Ends 2023 Strongby Mark Eisenberg 16.02.2024Canadian wholesale trade experienced a slight softening in December, but ended the year on a positive note with rising sales ...
SHE Beverage Execs Fined $12.7M in SEC Fraud Caseby Mark Eisenberg 16.02.2024Lancaster-based beverage company SHE Beverage Co. has been ordered to pay $12.7 million for alleged investor fraud, while CEO Lupe ...
Antero Resources: Growth Through Operational Efficiencyby Mark Eisenberg 16.02.2024Antero Resources Corporation achieves robust progress in 2023, forecasts positive outlook for 2024 with increased volumes, positive cash flow, and ...
Oil Prices Slide Amid Demand Worries, Weekly Gains Holdby Mark Eisenberg 16.02.2024Oil prices dipped in Asian trade as demand concerns persisted. Weak economic readings and a warning from the IEA added ...
Hanesbrands Tumbles: Is It Time to Buy the Dip?by Mark Eisenberg 15.02.2024Hanesbrands stock drops 13.3% after poor earnings report and weak guidance. Potential for recovery with cost-cutting efforts, but caution advised ...
West Pharma Struggles: Shares Dip Amid Dim 2024 Outlookby Mark Eisenberg 15.02.2024West Pharmaceutical Services experiences a significant drop in stock value due to a dim forecast for 2024, with lower sales ...